Prime Medicine Prices 125 Million Dollar Offering

Company Prime Medicine Event Type Public offering pricing (~$125 million gross) Modality Prime editing Asset Prime-editing pipeline Target Not applicable Disease Area Genetic disease (liver, lung, immunology/oncology programs) Summary Meaningful update to the November 10 proposed offering: Prime Medicine subsequently priced 35,714,286 shares at $3.50…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *